IT1307850B1 - Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio - Google Patents

Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio

Info

Publication number
IT1307850B1
IT1307850B1 IT1999FI000051A ITFI990051A IT1307850B1 IT 1307850 B1 IT1307850 B1 IT 1307850B1 IT 1999FI000051 A IT1999FI000051 A IT 1999FI000051A IT FI990051 A ITFI990051 A IT FI990051A IT 1307850 B1 IT1307850 B1 IT 1307850B1
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
salt
carbohydratin
absorbable
composition based
Prior art date
Application number
IT1999FI000051A
Other languages
English (en)
Inventor
Giovanna Galli
Original Assignee
Italmed Di Galli Giovanna E Pa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italmed Di Galli Giovanna E Pa filed Critical Italmed Di Galli Giovanna E Pa
Priority to IT1999FI000051A priority Critical patent/IT1307850B1/it
Publication of ITFI990051A0 publication Critical patent/ITFI990051A0/it
Priority to EP00914133A priority patent/EP1162987B1/en
Priority to PCT/EP2000/002271 priority patent/WO2000054788A1/en
Priority to DE60000825T priority patent/DE60000825T2/de
Priority to AU35558/00A priority patent/AU3555800A/en
Priority to AT00914133T priority patent/ATE228001T1/de
Priority to ES00914133T priority patent/ES2188521T3/es
Publication of ITFI990051A1 publication Critical patent/ITFI990051A1/it
Application granted granted Critical
Publication of IT1307850B1 publication Critical patent/IT1307850B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
IT1999FI000051A 1999-03-15 1999-03-15 Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio IT1307850B1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT1999FI000051A IT1307850B1 (it) 1999-03-15 1999-03-15 Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio
EP00914133A EP1162987B1 (en) 1999-03-15 2000-03-15 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
PCT/EP2000/002271 WO2000054788A1 (en) 1999-03-15 2000-03-15 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
DE60000825T DE60000825T2 (de) 1999-03-15 2000-03-15 Pharmazeutische zusammensetzungen für medizinische und veterinäre verwendung zur verbesserung der darmflora bei dyspeptischem syndrom und diarrhoeen auf dem veterinärsektor
AU35558/00A AU3555800A (en) 1999-03-15 2000-03-15 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
AT00914133T ATE228001T1 (de) 1999-03-15 2000-03-15 Pharmazeutische zusammensetzungen für medizinische und veterinäre verwendung zur verbesserung der darmflora bei dyspeptischem syndrom und diarrhoeen auf dem veterinärsektor
ES00914133T ES2188521T3 (es) 1999-03-15 2000-03-15 Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999FI000051A IT1307850B1 (it) 1999-03-15 1999-03-15 Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio

Publications (3)

Publication Number Publication Date
ITFI990051A0 ITFI990051A0 (it) 1999-03-15
ITFI990051A1 ITFI990051A1 (it) 2000-09-15
IT1307850B1 true IT1307850B1 (it) 2001-11-19

Family

ID=11352845

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999FI000051A IT1307850B1 (it) 1999-03-15 1999-03-15 Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio

Country Status (7)

Country Link
EP (1) EP1162987B1 (it)
AT (1) ATE228001T1 (it)
AU (1) AU3555800A (it)
DE (1) DE60000825T2 (it)
ES (1) ES2188521T3 (it)
IT (1) IT1307850B1 (it)
WO (1) WO2000054788A1 (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108030096A (zh) * 2017-12-18 2018-05-15 浙江民生健康科技有限公司 一种钙铁锌与益生菌组合物及其应用

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6383534B1 (en) * 2000-01-18 2002-05-07 Lorin Dyrr Mineral water composition
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
DE10104055A1 (de) * 2001-01-31 2002-08-14 Suedzucker Ag Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren
WO2003013558A1 (en) * 2001-07-30 2003-02-20 Claudio De Simone Treatment of radiation-induced diarrhea with probiotics
US6936598B2 (en) * 2003-11-21 2005-08-30 Hill's Pet Nutrition, Inc. Composition and method
CA2470090A1 (fr) 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
ES2277550B1 (es) * 2005-12-21 2008-06-16 Laboratorios Casen-Fleet, S.L. Kit farmaceutico para la preparacion de una sal de hidratacion con un probiotico para bebes.
WO2009128523A1 (ja) 2008-04-17 2009-10-22 味の素株式会社 免疫賦活剤
DE102008059070B4 (de) 2008-11-26 2019-05-16 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur therapeutischen oder prophylaktischen Behandlung von Durchfallerkrankungen und/oder zur Aufrechterhaltung und/oder Wiederherstellung der natürlichen Darmflora, Dosiereinheit, Verpackungseinheit und Verwendung der Zusammensetzung
FI122247B (fi) 2009-08-12 2011-10-31 Vetcare Oy Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi
FR2974512B1 (fr) * 2011-04-28 2013-11-08 Roquette Freres Composition anti-inflammatoire de l'intestin comprenant du maltitol
EP2604123A1 (en) 2011-12-15 2013-06-19 Friesland Brands B.V. Method and nutritional compositions for the treatment of diarrhea.
ITMI20131467A1 (it) * 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
MA45327A (fr) 2016-05-13 2019-03-20 Sofar Spa Utilisation de probiotiques pour améliorer l'absorption des protéines
MA45288A (fr) 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
CN108203702A (zh) * 2016-12-20 2018-06-26 北京中科星冠生物技术股份有限公司 一种复合益生菌解酒饮料及其专用复合益生菌
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI84874C (fi) * 1989-11-02 1992-02-10 Valio Meijerien Foerfarande foer inkapsling av biologiskt aktiva aemnen, enligt metoden framstaelld kapsel, dess anvaendning och foder innehaollande den.
FR2674755B1 (fr) * 1991-04-05 1995-02-03 Thorel Jean Noel Nouvelles compositions medicamenteuses immunostimulatrices.
WO1993000012A1 (en) * 1991-06-28 1993-01-07 Pioneer Hi-Bred Internatinal, Inc. Manipulation of intestinal structure and enzymes in animals
SE513815C2 (sv) * 1995-08-25 2000-11-06 Wasa Medicals Ab Förfarande för framställning av tabletter innehållande levande mikroorganismer och med oligosacharider i tablettmaterialet

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108030096A (zh) * 2017-12-18 2018-05-15 浙江民生健康科技有限公司 一种钙铁锌与益生菌组合物及其应用

Also Published As

Publication number Publication date
ITFI990051A1 (it) 2000-09-15
EP1162987A1 (en) 2001-12-19
AU3555800A (en) 2000-10-04
ES2188521T3 (es) 2003-07-01
DE60000825D1 (de) 2003-01-02
ATE228001T1 (de) 2002-12-15
EP1162987B1 (en) 2002-11-20
ITFI990051A0 (it) 1999-03-15
DE60000825T2 (de) 2003-09-04
WO2000054788A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
IT1307850B1 (it) Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio
BR0313185A (pt) Probióticos para funções neuromusculares intestinais
YU22794A (sh) Veterinarska kompozicija
MY115351A (en) Pharmaceutical formulations
BR0016231A (pt) Composição compreendendo enzima com capacidade de clivar uma ligação que efetua a liberação de uma proteìna ou carboidrato de superfìcie celular para ser usada no tratamento de infecções
TR199901447T2 (xx) �nsan veya hayvan sindirim yolunda nitrik oksit salabilen propiyonik bakterileri i�eren emici terkip.
ATE79265T1 (de) Mittel zur behandlung mykotischer, mikrobischer und anderer gewebsschaedigender und pathologischer manifestationen und gewebsdeformationen.
PT975581E (pt) Composicoes solidas adequadas para administracao oral compreendendo tartarato de l-carnitina e colina ou de alcanoil-l-carnitina e colina
Hubbard Periodontal disease and the family physician
ATE285757T1 (de) Inaktivierte mikroorganismen, die pharmakologisch aktive substanzen enthalten
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
ATE203160T1 (de) Tierärztliche behandlung
NO308707B1 (no) Anvendelse av et vandig næringsmedium for formering av homofermentative melkesyrebakterier under usterile betingelser for tilsetning som sileringsmiddel til det er et for
Coates Life without microbes
Johnson Lameness and foot care of small ruminants.
MXPA99005235A (es) Composicion antibacteriana oral veterinaria de fluoroquinolona para duracion extendida de terapia ymetodo de tratamiento.
RU95118193A (ru) Штамм бактерий bifidobacterium coturnix, используемый для приготовления пробиотического препарата для птицеводства и ветеринарии
BR9612813A (pt) Composição antibacteriana de fluoroquinolona veterinária oral para duração prolongada de terapia e método de tratamento
BRPI0403271A (pt) composição de liberação in vivo
RU99124523A (ru) Способ комплексного лечения больных нейродермитом
WO1997037631A3 (en) Chemotherapeutic veterinary drug containing oxytetracycline, sulfadimidine and neomycin